7 colorectal cancer warning signs younger adults should never ignore

Colorectal cancer has traditionally been thought of as a disease of older age, screened for routinely starting around 45 or 50. But it has quietly become the leading cause of cancer death among people under 50 in several countries, and the number of younger adults diagnosed each year continues to climb even as overall cancer rates in that age group have generally fallen. Researchers have not settled on a single explanation for the rise, with diet, obesity, sedentary lifestyles, and changes in gut bacteria all under investigation as possible contributing factors.
Because colorectal cancer is not yet routinely screened for in people under the standard threshold age, younger patients are more likely to be diagnosed only after symptoms appear, sometimes at a more advanced stage than an older patient caught through routine screening. That makes recognizing early warning signs especially important for anyone under 45, even though most of the symptoms below have far more common and harmless explanations, from hemorrhoids to irritable bowel syndrome to a simple stomach bug.
The first sign to take seriously is a persistent change in bowel habits, meaning diarrhea, constipation, or a noticeable change in stool frequency that lasts more than a few weeks rather than resolving on its own. Everyone's digestive system fluctuates occasionally, but a change that persists, rather than passing within days, is different from ordinary variation and is worth mentioning to a doctor.
Rectal bleeding or blood in the stool is the symptom most commonly associated with colorectal cancer in public awareness campaigns, and for good reason. It is also extremely commonly caused by hemorrhoids or minor anal fissures, which are far more likely explanations in most cases. The distinction doctors draw is less about the presence of blood and more about whether it recurs, since a one-off instance is less concerning than bleeding that keeps happening.
Dark, tarry, or unusually narrow stools are a related but distinct sign worth separating out. Darker blood, as opposed to the bright red blood typical of hemorrhoids, can indicate bleeding higher in the digestive tract and generally warrants prompt medical attention. A persistent change in stool shape, particularly narrower, ribbon-like stools, can in some cases reflect a growth partially obstructing the colon, though this is one of the less common warning signs.
Unexplained weight loss, meaning a noticeable drop in weight without a corresponding change in diet or exercise, is a warning sign associated with a wide range of serious conditions, colorectal cancer among them. Because weight naturally fluctuates for countless benign reasons, doctors generally focus on cases where the loss is significant, unintentional, and sustained over weeks rather than a single fluctuation.
Persistent fatigue that does not improve with rest can be an indirect sign, often linked to anemia caused by chronic, low-level blood loss in the digestive tract that a person may not otherwise notice. This kind of fatigue tends to be described as different from ordinary tiredness, more pervasive and less responsive to sleep or rest than fatigue from an obvious cause like poor sleep or overwork.
Abdominal pain, cramping, or bloating that persists rather than coming and going with meals or bowel movements is another sign clinicians flag, particularly when it does not have an obvious dietary trigger and does not resolve within a few weeks. Digestive discomfort is common and usually benign, but persistence and a lack of an obvious pattern are what tend to prompt further investigation.
A final sign worth noting is a persistent feeling of incomplete bowel emptying, sometimes described as a sense that something remains even immediately after a bowel movement. Like several of the other signs on this list, it is nonspecific and has many possible benign causes, but is worth mentioning to a doctor if it persists for more than a few weeks rather than resolving.
Doctors emphasize that having one or even several of these symptoms does not mean a person has colorectal cancer; the overwhelming majority of cases involving these signs turn out to have far more common, treatable explanations. The consistent advice from clinicians and cancer organizations is not to self-diagnose in either direction, but to raise persistent or unusual symptoms with a doctor rather than dismissing them, since early detection significantly improves treatment outcomes for the cases that do turn out to be cancer.
Read next

Antibiotic resistance: how scientists revived a powerful drug that superbugs had defeated
Vancomycin, once one of medicine's most reliable last-resort antibiotics, had been losing its power against drug-resistant bacteria. By pairing it with a small molecule that blocks a resistance-linked enzyme, researchers restored its ability to kill drug-resistant E. faecium, pointing to a new strategy against antimicrobial resistance.

Why former CDC officials say the US is less prepared for disease outbreaks
As measles, hantavirus, cyclospora and other outbreaks spread across the US this year, former officials at the Centers for Disease Control and Prevention say staffing and funding cuts have widened gaps in the country's ability to detect and respond to infectious disease.

Defibrillator deserts: why millions in England and Wales live too far from a life-saving device
New research from the Heart Restart campaign finds more than 16 million people in England and Wales live more than a 1km round trip from a 24/7 accessible defibrillator, raising their risk of dying from a cardiac arrest. Here is why proximity to a defibrillator matters so much, and why so many communities still lack one.

What is a 'world model', and why some AI researchers see it as an alternative to LLMs
As large language models dominate the AI conversation, some researchers argue a different approach, called a world model, may be better suited to tasks like medical scribing. Nabla's Alex LeBrun explains the concept and why it is drawing renewed attention.

Fampridine: the MS drug now on the NHS and how it helps patients walk
England's NHS has approved fampridine, a drug that improves nerve signalling and helps people with multiple sclerosis walk more easily, for up to 5,000 eligible patients. Here is how the decades-old drug works and why it took so long to reach the NHS.